Skip to content
☰ Menu
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Aging Biomarkers, Geriatric Assessment and Electronic Frailty Index (AGE)

Authors not listed

Wake Forest University Health Sciences · 2022

Loss of proteostasis Human Randomized controlled trial
＋ Sign in to save

Abstract

The purpose of this research study is to compare methods to help personalize the prediction of chemotherapy side effects for older adults and to evaluate whether chemotherapy causes changes in the body that are associated with aging.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-07-02 MST

Cite this

APA
Anonymous. (2022). Aging Biomarkers, Geriatric Assessment and Electronic Frailty Index (AGE). <em>Wake Forest University Health Sciences</em>. https://clinicaltrials.gov/study/NCT05268991
Vancouver
Anonymous. Aging Biomarkers, Geriatric Assessment and Electronic Frailty Index (AGE). Wake Forest University Health Sciences. 2022.
BibTeX
@misc{anon2022AgingB, title = {Aging Biomarkers, Geriatric Assessment and Electronic Frailty Index (AGE)}, author = {Anonymous}, journal = {Wake Forest University Health Sciences}, year = {2022}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings